Henry Schein Inc
$ 84.61
-1.01%
27 Jul - close price
- Market Cap 9,736,465,000 USD
- Current Price $ 84.61
- High / Low $ 86.56 / 84.47
- Stock P/E 25.82
- Book Value 28.54
- EPS 3.31
- Next Earning Report 2026-08-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.09 %
- 52 Week High 89.34
- 52 Week Low 61.95
About
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Analyst Target Price
$88.50
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-13 | 2023-08-07 |
| Reported EPS | 1.32 | 1.34 | 1.38 | 1.1 | 1.15 | 1.19 | 1.22 | 1.23 | 1.1 | 0.66 | 1.32 | 1.31 |
| Estimated EPS | 1.22 | 1.3 | 1.28 | 1.19 | 1.11 | 1.2089 | 1.17 | 1.22 | 1.01 | 0.69 | 1.32 | 1.28 |
| Surprise | 0.1 | 0.04 | 0.1 | -0.09 | 0.04 | -0.0189 | 0.05 | 0.01 | 0.09 | -0.03 | 0 | 0.03 |
| Surprise Percentage | 8.1967% | 3.0769% | 7.8125% | -7.563% | 3.6036% | -1.5634% | 4.2735% | 0.8197% | 8.9109% | -4.3478% | 0% | 2.3438% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-04 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.22 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HSIC
2026-07-27 17:16:00
Shares of Henry Schein Inc. (HSIC) fell by 1.01% on Monday, closing at $84.61, despite a generally favorable trading day for the broader market. The S&P 500 Index and the Dow Jones Industrial Average both saw gains. Henry Schein Inc. ended the day 5.30% below its 52-week high of $89.34, achieved on July 16th.
2026-07-27 13:09:07
Stryker (SYK) is expected to show recovery in its second-quarter 2026 results from a cyber incident that disrupted its first-quarter shipments. Analysts anticipate healthy underlying performance driven by procedural demand and robotic surgery adoption, with earnings projected to increase by 10.5% and revenues by 8.9%. The company aims to recover deferred revenues and maintain its full-year EPS guidance despite tariff and cost pressures.
2026-07-27 13:07:41
DexCom, Inc. (DXCM) is anticipated to report strong second-quarter 2026 results, driven by robust demand for its G7 continuous glucose monitoring (CGM) systems and expanded reimbursement coverage, particularly for non-insulin type 2 diabetes patients. The company's U.S. and international operations are expected to show significant momentum, supported by new product execution and increased physician awareness. Despite a positive outlook for revenue growth and operating margin, the Zacks Model does not conclusively predict an earnings beat due to a negative Earnings ESP.
2026-07-27 12:38:53
This article details the shareholder structure of Henry Schein Inc (HSIC), listing its major shareholders, their proportionate holdings, and categorizing shareholders by type such as investment advisors, private equity firms, and hedge funds. It also provides a historical overview of institutional holdings and recent shareholder activity, indicating changes in the number of shares held by major investment entities. The information is updated as of May and April 2026 for various sections.
2026-07-26 06:42:14
This article emphasizes that Henry Schein's stock performance is primarily driven by its earnings, margins, and market value, rather than market chatter. It highlights the importance of analyzing the company's net sales, profitability, and margin trends from its latest financial reports to understand stock movements. The piece also notes Henry Schein's exposure to dental, medical, and animal-health markets as key drivers.
2026-07-24 23:37:58
This Yahoo Finance page provides comprehensive information on Henry Schein, Inc. (HSIC), including its current stock price, historical data, recent news, and key financial metrics. The article details the company's business segments, performance overview compared to the S&P 500, analyst insights, and valuation measures. It also allows for comparison with similar companies in the medical distribution industry.
